1 / 8

Allergic Asthma Therapeutics Market Size, Share, Outlook, and Opportunity Analysis, 2020– 2027

Allergic Asthma Therapeutics Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.

SANJAYCMI
Download Presentation

Allergic Asthma Therapeutics Market Size, Share, Outlook, and Opportunity Analysis, 2020– 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ALLERGIC ASTHMA THERAPEUTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Allergic Asthma Therapeutics Market - Overview Global Allergic Asthma Therapeutics Market, by Drug Type (Corticosteroids, Bronchodilators, Leukotriene modifiers, Immunotherapy, Biologics, and Others), by Route of Administration (Oral, Inhaled, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is expected to be valued at US$ 6,704.8 million in 2020 and is estimated to exhibit a CAGR of 2.93% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. In June 2017, Teva Pharmaceuticals Industries Ltd. received the U.S. FDA approval for its three products; ArmonAir, RespiClick, and AirDuo RespiClick. These are asthma inhalers for adult as well as adolescent patients suffering from asthma. ArmonAir and AirDuo are available by prescription to patients in the U.S. The approved strengths of ArmonAir is 232 mcg, 55 mcg, and 113 mcg, whereas, the approved strengths of AirDuo is 232/14 mcg, 55/14 mcg, and 113/14 mcg, and 55/14 mcg, directed as one inhalation twice daily. Besides, Regeneron Pharmaceuticals, Inc. and Sanofi, in October 2018, received FDA approval for Dupixent (dupilumab), as an added maintenance therapy for patients with moderate-to- severe asthma. ASLAN004 helps in triggering the symptoms of allergic asthma such as wheezing, shortness of breath, coughing, and exacerbations of the disease Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/allergic- asthma-therapeutics-market-4019 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Global Allergic Asthma Therapeutics Market - Impact of Coronavirus (Covid-19) Pandemic The allergic asthma therapeutics market growth is hugely impacted by the sudden outbreak of COVID-19 all across the globe. Though the risk of asthma patients to be affected by COVID-19 is higher, authorities are taking utmost precaution to make the critical solutions (ventilators, inhalers) available to the patients. Supply for respiratory medications have not been affected due this pandemic. The comprehensive version of the report will include COVID-19’s impact and the projected changes in the future outlook of the industry, by taking into the account the social, economic, political, and technological parameters. Browse 24 Market Data Tables and 26 Figures spread through 170 Pages and in-depth TOC on Allergic Asthma Therapeutics Market, by Drug Type (Corticosteroids, Bronchodilators, Leukotriene modifiers, Immunotherapy, Biologics, and Others), by Route of Administration (Oral, Inhaled, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Forecast to 2027” For instance, in May 2019, Singapore-based biopharma company, ASLAN Pharmaceuticals, revised its license agreement with CSL Limited (CSL) to have full global rights for developing, manufacturing, and commercializing ASLAN004 in all indications. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4019 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Key Takeaways of the Global Allergic Asthma Therapeutics Market: The allergic asthma therapeutics market is expected to exhibit a CAGR of 2.9% during the forecast period (2020-2027) owing to the rising number of respiratory diseases, and strategic collaborations and joint ventures among market players. Pipeline products from AstraZeneca, Sanofi, GSK, AB Science, Mundipharma, Shanghai Biomabs Pharmaceutical Co., Ltd., and Chiesi Farmaceutici among others would transcend the market scenario in near future, with their innovative single as well as combination asthma treatment products. Major players operating in the allergic asthma therapeutics market are Aslan Pharmaceuticals Pte. Ltd., Baxalta Incorporated, Axikin Pharmaceuticals, Chiesi Farmaceutici SpA, CSL Limited, Circassia Pharmaceuticals Plc, Fountain Biopharma Inc., Hydra Biosciences, GlaxoSmithKline Plc, Infinity Pharmaceuticals, Mabtech Limited, Kineta, Marinomed Biotechnologie Gmb, NeoPharm Co., Mycenax Biotech Inc., Panacea Biotec Limited, and Oxagen Limited. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4019 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related